Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTT-936 Alone or With Anti-PD-1/L1 in Advanced Solid Tumors
NCT06244992Phase 2Recruiting
- Sponsor
- Pyrotech Therapeutics
- Start
- Jan 2024
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of PTT-936 in solid tumor, sponsored by Pyrotech Therapeutics. Started Jan 2024; status: recruiting.
02
Drugs
PTT-936
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06244992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06244992.